A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy

F Zhang, S Lv, Y Feng, X Yang, W Qiang - BMC Health Services Research, 2019 - Springer
F Zhang, S Lv, Y Feng, X Yang, W Qiang
BMC Health Services Research, 2019Springer
Background Skin rash remains one of the most prevalent and troublesome clinical problems
experienced by patients on chemotherapy and targeted therapy. To ensure high-quality
care, guidelines are seen as the best guidance. Considering the quality of guidelines varies
greatly, a systematical appraisal of the methodological quality of guidelines for the
management of skin rash in patients on chemotherapeutic drugs and targeted anticancer
therapies was undertaken, in order to identify appropriate ones for healthcare professionals …
Background
Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical appraisal of the methodological quality of guidelines for the management of skin rash in patients on chemotherapeutic drugs and targeted anticancer therapies was undertaken, in order to identify appropriate ones for healthcare professionals.
Methods
A systematic search of databases and Internet was conducted to obtain pertinent guidelines. Two reviewers independently assessed the eligibility of guidelines according to the inclusion criteria. Then the guidelines included were appraised by three researchers with the methodological quality of eligible guideline using Appraisal of Guidelines for Research and Evaluation II (AGREEII).
Results
Totally nineteen guidelines met the inclusion criteria. The quality ranged from good to acceptable in scope and purpose (mean: 78.80%, range: 66.67–94.44%) and clarity of presentation domains (mean: 85.38%, 75.00–91.67%), but not in stakeholder involvement (mean: 50.15%, range: 36.11–75.00%), rigor of development (mean: 23.65%, range: 6.25–70.83%), applicability (mean: 23.96%, range: 4.17–52.08%), and editorial independence domains (mean: 45.18%, range: 0.00–87.50%). Overall, two guidelines were classified as “recommended”.
Conclusions
Only two guidelines were recommended to manage skin rash in patients on chemotherapy and targeted therapies, most guidelines issued were of low to moderate quality. Thus, more attention should be paid to the methodological quality of guideline development in this field.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果